Share Facebook Twitter LinkedIn Pinterest Email MARLBOROUGH, Mass. , May 2, 2022 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) will participate in Bank of America’s Global Healthcare Conference on Thursday, May 12.
Amylyx Pharmaceuticals to Announce Plans for an Open Label Extension (OLE) Phase for Global PHOENIX Trial of AMX0035 in ALS at the 17th International Congress on Neuromuscular DiseasesJuly 6, 2022
